To wrap up Mental Health Awareness Month, singer-songwriter Marcus King joins Going There with Dr. Mike for an honest, open conversation about his experience being bipolar. Listen as King shares his ...

Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - - ...

Alkermes plc (Nasdaq: ALKS) today announced plans to present three posters related to ALKS 2680 at SLEEP 2024, the 38th ...

Alkermes (NASDAQ:ALKS) is making strides in the biotech space. The company is active in areas of critical and chronic ...

Baird raised the price target for the Alkermes plc (NASDAQ:ALKS) stock to “an Outperform”. The rating was released on March 19, 2024, according to finviz. The research report from JP Morgan has ...

Alkermes (NASDAQ:ALKS) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives ...

Market OverviewThe Addiction Rehab Facilities Market, valued at USD 16.8 billion in 2023, is anticipated to experience substantial growth, reaching about USD 31.3 billion by 2032. This growth ...

Investors in Alkermes plc ALKS need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, 2024 $34 Call had some of the highest implied ...

The Kiwanis Club of Wilmington held its annual Bike Rodeo on Saturday starting at the parking lot of Clinton Memorial ...

Alkermes is positioned for outperformance due to its conservative cash-heavy balance sheet and high-margin business model.

The price-to-earnings ratio for Alkermes plc (NASDAQ:ALKS) is 9.65. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E ...

The Global Schizophrenia Drugs Market is projected to grow significantly, with an expected market size of USD 12.6 billion by 2032, up from USD 7.4 billion in 2022, at a compound annual growth rate ...